pamidronate has been researched along with Dermatomyositis in 6 studies
Dermatomyositis: A subacute or chronic inflammatory disease of muscle and skin, marked by proximal muscle weakness and a characteristic skin rash. The illness occurs with approximately equal frequency in children and adults. The skin lesions usually take the form of a purplish rash (or less often an exfoliative dermatitis) involving the nose, cheeks, forehead, upper trunk, and arms. The disease is associated with a complement mediated intramuscular microangiopathy, leading to loss of capillaries, muscle ischemia, muscle-fiber necrosis, and perifascicular atrophy. The childhood form of this disease tends to evolve into a systemic vasculitis. Dermatomyositis may occur in association with malignant neoplasms. (From Adams et al., Principles of Neurology, 6th ed, pp1405-6)
| Excerpt | Relevance | Reference |
|---|---|---|
| "Juvenile dermatomyositis is a rare systemic autoimmune disease wth calcinosis as its hallmark sequelae." | 5.56 | Pamidronate in Treatment of Calcinosis in Juvenile Dermatomyositis. ( Dash, M; Giri, S; Panda, M; Parida, JR, 2020) |
| "A 7-year-old girl with juvenile dermatomyositis developed severe calcinosis, despite an extensive medication regimen." | 5.40 | Improvement of calcinosis using pamidronate in a patient with juvenile dermatomyositis. ( Martillotti, J; Moote, D; Zemel, L, 2014) |
| "A 14-year-old girl with juvenile dermatomyositis developed extensive and debilitating calcinosis, unresponsive to colchicine, while muscle involvement subsided." | 5.36 | Complete resolution of universal calcinosis in a patient with juvenile dermatomyositis using pamidronate. ( Abdessemed, A; Haddouche, A; Ladjouze-Rezig, A; Slimani, S, 2010) |
| "Juvenile dermatomyositis is a rare systemic autoimmune disease wth calcinosis as its hallmark sequelae." | 1.56 | Pamidronate in Treatment of Calcinosis in Juvenile Dermatomyositis. ( Dash, M; Giri, S; Panda, M; Parida, JR, 2020) |
| "A 7-year-old girl with juvenile dermatomyositis developed severe calcinosis, despite an extensive medication regimen." | 1.40 | Improvement of calcinosis using pamidronate in a patient with juvenile dermatomyositis. ( Martillotti, J; Moote, D; Zemel, L, 2014) |
| "A 14-year-old girl with juvenile dermatomyositis developed extensive and debilitating calcinosis, unresponsive to colchicine, while muscle involvement subsided." | 1.36 | Complete resolution of universal calcinosis in a patient with juvenile dermatomyositis using pamidronate. ( Abdessemed, A; Haddouche, A; Ladjouze-Rezig, A; Slimani, S, 2010) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (16.67) | 29.6817 |
| 2010's | 4 (66.67) | 24.3611 |
| 2020's | 1 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Giri, S | 1 |
| Parida, JR | 1 |
| Dash, M | 1 |
| Panda, M | 1 |
| Martillotti, J | 1 |
| Moote, D | 1 |
| Zemel, L | 1 |
| Palaniappan, P | 1 |
| Lionel, AP | 1 |
| Kumar, S | 1 |
| Slimani, S | 1 |
| Abdessemed, A | 1 |
| Haddouche, A | 1 |
| Ladjouze-Rezig, A | 1 |
| Bayou, F | 1 |
| Belajouza, C | 1 |
| Boussofara, L | 1 |
| Ghariani, N | 1 |
| Denguezli, M | 1 |
| Bouajina, E | 1 |
| Nouira, R | 1 |
| Damiani, D | 1 |
6 other studies available for pamidronate and Dermatomyositis
| Article | Year |
|---|---|
Pamidronate in Treatment of Calcinosis in Juvenile Dermatomyositis.
Topics: Calcinosis; Child; Child, Preschool; Dermatomyositis; Female; Fingers; Humans; Male; Pamidronate | 2020 |
Improvement of calcinosis using pamidronate in a patient with juvenile dermatomyositis.
Topics: Bone Density Conservation Agents; Calcinosis; Child; Dermatomyositis; Diphosphonates; Female; Humans | 2014 |
Successful treatment of calcinosis cutis in juvenile dermatomyositis with pamidronate.
Topics: Calcinosis; Child; Dermatomyositis; Diphosphonates; Dose-Response Relationship, Drug; Drug Administr | 2014 |
Complete resolution of universal calcinosis in a patient with juvenile dermatomyositis using pamidronate.
Topics: Adolescent; Bone Density Conservation Agents; Calcinosis; Calcium; Cholecalciferol; Dermatomyositis; | 2010 |
[Aggressive universal calcinosis complicating dermatomyositis].
Topics: Adolescent; Anti-Bacterial Agents; Calcinosis; Combined Modality Therapy; Cutaneous Fistula; Dermato | 2011 |
Metaphyseal sclerosis associated with bisphosphonate therapy.
Topics: Alendronate; Bone and Bones; Bone Density Conservation Agents; Dermatomyositis; Diphosphonates; Huma | 2007 |